Argatroban injection is also indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
The Medicines Company senior vice president and chief customer officer Brent Furse said Argatroban is an important drug in the treatment of heparin-induced thrombocytopenia, including in patients with life-threatening thrombosis syndromes.
"Current Argatroban formulations available to hospital pharmacies include a concentrate formula that requires reconstitution to 250ml and a package of two pre-mixed 125ml vials," Furse said.